
Featured
Canadian Scientists Prepare to Launch Clinical Trials for Pancreatic Cancer Pill That Doubles Survival Time
A Canadian pancreatic cancer specialist is preparing to launch clinical trials for daraxonrasib, a breakthrough pill that targets specific mutations a...
Read Full Story →